By continuing to use the site you agree to our Privacy & Cookies policy

MS drug approved for use in EU

A new treatment for multiple sclerosis has been approved by the European Medicines Agency, while reviewers have called for more evidence on another drug for the condition.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units